Then, FXYD6 expression was measured in five clinically matched CRC tissue samples and adjacent tissue samples by RT-PCR; the result also indicated that FXYD6 was decreased in CRC (Figure 1(c)). Here, FXYD6 is linked to colorectal carcinoma.